VANGUARD GROUP INC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$20,497,776
+15.4%
948,532
+3.4%
0.00%0.0%
Q3 2022$17,763,000
-10.0%
917,480
-7.7%
0.00%0.0%
Q2 2022$19,741,000
-32.3%
993,970
+1.7%
0.00%0.0%
Q1 2022$29,164,000
+33.9%
977,665
+4.5%
0.00%
Q4 2021$21,786,000
-26.6%
935,430
-1.7%
0.00%
-100.0%
Q3 2021$29,684,000
-8.7%
951,406
+2.9%
0.00%0.0%
Q2 2021$32,521,000
+1.7%
924,397
+1.9%
0.00%0.0%
Q1 2021$31,963,000
-3.8%
906,725
+2.4%
0.00%0.0%
Q4 2020$33,226,000
+247.4%
885,800
+209.0%
0.00%
Q3 2020$9,565,000
+44.4%
286,623
+14.6%
0.00%
Q2 2020$6,624,000
+72.2%
250,051
+6.4%
0.00%
Q1 2020$3,846,000
-29.3%
234,944
+9.8%
0.00%
Q4 2019$5,438,000
+31.5%
213,937
+3.4%
0.00%
Q3 2019$4,136,000
-27.8%
206,814
+16.4%
0.00%
Q2 2019$5,727,000
+10.2%
177,647
+10.1%
0.00%
Q1 2019$5,199,000
+34.8%
161,411
+2.7%
0.00%
Q4 2018$3,857,000
-7.9%
157,232
+23.8%
0.00%
Q3 2018$4,186,000
-6.3%
127,006
+0.9%
0.00%
Q2 2018$4,469,000
+47.1%
125,897
+35.0%
0.00%
Q1 2018$3,039,000
+282.7%
93,281
+200.7%
0.00%
Q4 2017$794,000
+26.4%
31,019
+3.5%
0.00%
Q3 2017$628,0000.0%29,963
-1.7%
0.00%
Q2 2017$628,000
-12.4%
30,469
+2.0%
0.00%
Q1 2017$717,000
+42.0%
29,869
+4.9%
0.00%
Q4 2016$505,00028,4650.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders